Eintrag weiter verarbeiten
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients
Gespeichert in:
| Zeitschriftentitel: | Alimentary Pharmacology & Therapeutics |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Alimentary Pharmacology & Therapeutics, 28, 2008, 2, S. 250-255 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. |
|---|---|
| author |
CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. |
| spellingShingle |
CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. Alimentary Pharmacology & Therapeutics Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients Pharmacology (medical) Gastroenterology Hepatology |
| author_sort |
calabrese, c. |
| spelling |
CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. 0269-2813 1365-2036 Wiley Pharmacology (medical) Gastroenterology Hepatology http://dx.doi.org/10.1111/j.1365-2036.2008.03733.x <jats:title>Summary</jats:title><jats:p><jats:bold>Background </jats:bold> Comparative studies of proton pump inhibitors (PPIs) have revealed that acid reflux is influenced by PPI treatment, formulations and dosing regimens. Wireless pH capsules have circumvented some of the limitations of conventional catheter‐based pH testing with the additional advantage of 96‐h recording periods.</jats:p><jats:p><jats:bold>Aim </jats:bold> To clarify the effectiveness of intra‐oesophageal acid suppression by omeprazole, pantoprazole and lansoprazole in non‐erosive reflux disease patients through a 4‐day monitoring of oesophageal pH and related symptoms.</jats:p><jats:p><jats:bold>Methods </jats:bold> Twenty‐four patients with typical symptoms of gastro‐oesophageal reflux disease were enrolled and administered upper endoscopy and placement of a wireless pH capsule. Patients randomly received omeprazole, pantoprazole or lansoprazole for 3 days after the first 24 h. Symptom–reflux associations were expressed using the symptom index (SI).</jats:p><jats:p><jats:bold>Results </jats:bold> All patients completed the study. Significant decrease in acid exposure occurred on day 2 and in each successive day in all groups. Pantoprazole and omeprazole are more effective than lansoprazole at inducing a normalization of intra‐oesophageal acid exposure at days 2 and 3. Significant reduction in SI at day 2 was observed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> Four‐day ambulatory oesophageal pH monitoring is feasible and safe. Omeprazole, pantoprazole and lansoprazole have an equivalent potency for normalizing intra‐oesophageal acid exposure after 3 days of treatment in non‐erosive reflux disease patients.</jats:p> Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients Alimentary Pharmacology & Therapeutics |
| doi_str_mv |
10.1111/j.1365-2036.2008.03733.x |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA4LjAzNzMzLng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA4LjAzNzMzLng |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
| imprint |
Wiley, 2008 |
| imprint_str_mv |
Wiley, 2008 |
| issn |
0269-2813 1365-2036 |
| issn_str_mv |
0269-2813 1365-2036 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
calabrese2008ninetysixhourwirelessoesophagealphmonitoringfollowingprotonpumpinhibitoradministrationinnerdpatients |
| publishDateSort |
2008 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Alimentary Pharmacology & Therapeutics |
| source_id |
49 |
| title |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_unstemmed |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_full |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_fullStr |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_full_unstemmed |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_short |
Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_sort |
ninety‐six‐hour wireless oesophageal ph monitoring following proton pump inhibitor administration in nerd patients |
| topic |
Pharmacology (medical) Gastroenterology Hepatology |
| url |
http://dx.doi.org/10.1111/j.1365-2036.2008.03733.x |
| publishDate |
2008 |
| physical |
250-255 |
| description |
<jats:title>Summary</jats:title><jats:p><jats:bold>Background </jats:bold> Comparative studies of proton pump inhibitors (PPIs) have revealed that acid reflux is influenced by PPI treatment, formulations and dosing regimens. Wireless pH capsules have circumvented some of the limitations of conventional catheter‐based pH testing with the additional advantage of 96‐h recording periods.</jats:p><jats:p><jats:bold>Aim </jats:bold> To clarify the effectiveness of intra‐oesophageal acid suppression by omeprazole, pantoprazole and lansoprazole in non‐erosive reflux disease patients through a 4‐day monitoring of oesophageal pH and related symptoms.</jats:p><jats:p><jats:bold>Methods </jats:bold> Twenty‐four patients with typical symptoms of gastro‐oesophageal reflux disease were enrolled and administered upper endoscopy and placement of a wireless pH capsule. Patients randomly received omeprazole, pantoprazole or lansoprazole for 3 days after the first 24 h. Symptom–reflux associations were expressed using the symptom index (SI).</jats:p><jats:p><jats:bold>Results </jats:bold> All patients completed the study. Significant decrease in acid exposure occurred on day 2 and in each successive day in all groups. Pantoprazole and omeprazole are more effective than lansoprazole at inducing a normalization of intra‐oesophageal acid exposure at days 2 and 3. Significant reduction in SI at day 2 was observed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> Four‐day ambulatory oesophageal pH monitoring is feasible and safe. Omeprazole, pantoprazole and lansoprazole have an equivalent potency for normalizing intra‐oesophageal acid exposure after 3 days of treatment in non‐erosive reflux disease patients.</jats:p> |
| container_issue |
2 |
| container_start_page |
250 |
| container_title |
Alimentary Pharmacology & Therapeutics |
| container_volume |
28 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335945111961600 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:52:36.459Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Ninety%E2%80%90six%E2%80%90hour+wireless+oesophageal+pH+monitoring+following+proton+pump+inhibitor+administration+in+NERD+patients&rft.date=2008-07-01&genre=article&issn=1365-2036&volume=28&issue=2&spage=250&epage=255&pages=250-255&jtitle=Alimentary+Pharmacology+%26+Therapeutics&atitle=Ninety%E2%80%90six%E2%80%90hour+wireless+oesophageal+pH+monitoring+following+proton+pump+inhibitor+administration+in+NERD+patients&aulast=DI+FEBO&aufirst=G.&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.2008.03733.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335945111961600 |
| author | CALABRESE, C., LIGUORI, G., GABUSI, V., GIONCHETTI, P., RIZZELLO, F., STRAFORINI, G., BRUGNERA, R., DI FEBO, G. |
| author_facet | CALABRESE, C., LIGUORI, G., GABUSI, V., GIONCHETTI, P., RIZZELLO, F., STRAFORINI, G., BRUGNERA, R., DI FEBO, G., CALABRESE, C., LIGUORI, G., GABUSI, V., GIONCHETTI, P., RIZZELLO, F., STRAFORINI, G., BRUGNERA, R., DI FEBO, G. |
| author_sort | calabrese, c. |
| container_issue | 2 |
| container_start_page | 250 |
| container_title | Alimentary Pharmacology & Therapeutics |
| container_volume | 28 |
| description | <jats:title>Summary</jats:title><jats:p><jats:bold>Background </jats:bold> Comparative studies of proton pump inhibitors (PPIs) have revealed that acid reflux is influenced by PPI treatment, formulations and dosing regimens. Wireless pH capsules have circumvented some of the limitations of conventional catheter‐based pH testing with the additional advantage of 96‐h recording periods.</jats:p><jats:p><jats:bold>Aim </jats:bold> To clarify the effectiveness of intra‐oesophageal acid suppression by omeprazole, pantoprazole and lansoprazole in non‐erosive reflux disease patients through a 4‐day monitoring of oesophageal pH and related symptoms.</jats:p><jats:p><jats:bold>Methods </jats:bold> Twenty‐four patients with typical symptoms of gastro‐oesophageal reflux disease were enrolled and administered upper endoscopy and placement of a wireless pH capsule. Patients randomly received omeprazole, pantoprazole or lansoprazole for 3 days after the first 24 h. Symptom–reflux associations were expressed using the symptom index (SI).</jats:p><jats:p><jats:bold>Results </jats:bold> All patients completed the study. Significant decrease in acid exposure occurred on day 2 and in each successive day in all groups. Pantoprazole and omeprazole are more effective than lansoprazole at inducing a normalization of intra‐oesophageal acid exposure at days 2 and 3. Significant reduction in SI at day 2 was observed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> Four‐day ambulatory oesophageal pH monitoring is feasible and safe. Omeprazole, pantoprazole and lansoprazole have an equivalent potency for normalizing intra‐oesophageal acid exposure after 3 days of treatment in non‐erosive reflux disease patients.</jats:p> |
| doi_str_mv | 10.1111/j.1365-2036.2008.03733.x |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA4LjAzNzMzLng |
| imprint | Wiley, 2008 |
| imprint_str_mv | Wiley, 2008 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
| issn | 0269-2813, 1365-2036 |
| issn_str_mv | 0269-2813, 1365-2036 |
| language | English |
| last_indexed | 2024-03-01T14:52:36.459Z |
| match_str | calabrese2008ninetysixhourwirelessoesophagealphmonitoringfollowingprotonpumpinhibitoradministrationinnerdpatients |
| mega_collection | Wiley (CrossRef) |
| physical | 250-255 |
| publishDate | 2008 |
| publishDateSort | 2008 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Alimentary Pharmacology & Therapeutics |
| source_id | 49 |
| spelling | CALABRESE, C. LIGUORI, G. GABUSI, V. GIONCHETTI, P. RIZZELLO, F. STRAFORINI, G. BRUGNERA, R. DI FEBO, G. 0269-2813 1365-2036 Wiley Pharmacology (medical) Gastroenterology Hepatology http://dx.doi.org/10.1111/j.1365-2036.2008.03733.x <jats:title>Summary</jats:title><jats:p><jats:bold>Background </jats:bold> Comparative studies of proton pump inhibitors (PPIs) have revealed that acid reflux is influenced by PPI treatment, formulations and dosing regimens. Wireless pH capsules have circumvented some of the limitations of conventional catheter‐based pH testing with the additional advantage of 96‐h recording periods.</jats:p><jats:p><jats:bold>Aim </jats:bold> To clarify the effectiveness of intra‐oesophageal acid suppression by omeprazole, pantoprazole and lansoprazole in non‐erosive reflux disease patients through a 4‐day monitoring of oesophageal pH and related symptoms.</jats:p><jats:p><jats:bold>Methods </jats:bold> Twenty‐four patients with typical symptoms of gastro‐oesophageal reflux disease were enrolled and administered upper endoscopy and placement of a wireless pH capsule. Patients randomly received omeprazole, pantoprazole or lansoprazole for 3 days after the first 24 h. Symptom–reflux associations were expressed using the symptom index (SI).</jats:p><jats:p><jats:bold>Results </jats:bold> All patients completed the study. Significant decrease in acid exposure occurred on day 2 and in each successive day in all groups. Pantoprazole and omeprazole are more effective than lansoprazole at inducing a normalization of intra‐oesophageal acid exposure at days 2 and 3. Significant reduction in SI at day 2 was observed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> Four‐day ambulatory oesophageal pH monitoring is feasible and safe. Omeprazole, pantoprazole and lansoprazole have an equivalent potency for normalizing intra‐oesophageal acid exposure after 3 days of treatment in non‐erosive reflux disease patients.</jats:p> Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients Alimentary Pharmacology & Therapeutics |
| spellingShingle | CALABRESE, C., LIGUORI, G., GABUSI, V., GIONCHETTI, P., RIZZELLO, F., STRAFORINI, G., BRUGNERA, R., DI FEBO, G., Alimentary Pharmacology & Therapeutics, Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients, Pharmacology (medical), Gastroenterology, Hepatology |
| title | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_full | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_fullStr | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_full_unstemmed | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_short | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| title_sort | ninety‐six‐hour wireless oesophageal ph monitoring following proton pump inhibitor administration in nerd patients |
| title_unstemmed | Ninety‐six‐hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients |
| topic | Pharmacology (medical), Gastroenterology, Hepatology |
| url | http://dx.doi.org/10.1111/j.1365-2036.2008.03733.x |